Kbc Group Nv Emergent Bio Solutions Inc. Transaction History

Kbc Group Nv

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 15, 2024	SELL	$3.17 - $7.91 $1,337 - $3,338	-422 Reduced 12.98%	2,828 $10,000
Q2 2023 Feb 15, 2024	SELL	$7.35 - $13.21 $6,695 - $12,034	-911 Reduced 21.89%	3,250 $24,000
Q2 2023 Jul 28, 2023	SELL	$7.35 - $13.21 $6,695 - $12,034	-911 Reduced 21.89%	3,250 $24,000
Q4 2022 Feb 14, 2024	SELL	$11.0 - $21.45 $4,983 - $9,716	-453 Reduced 9.82%	4,161 $49,000
Q3 2022 Feb 15, 2024	BUY	$20.09 - $35.8 $83,594 - $148,963	4,161 New	4,161 $87,000
Q3 2022 Nov 08, 2022	SELL	$20.09 - $35.8 $9,100 - $16,217	-453 Reduced 9.82%	4,161 $87,000
Q2 2022 Feb 14, 2024	BUY	$27.42 - $43.63 $126,515 - $201,308	4,614 New	4,614 $143,000
Q2 2022 Jul 26, 2022	BUY	$27.42 - $43.63 $126,515 - $201,308	4,614 New	4,614 $143,000
Q4 2021 Feb 03, 2022	SELL	$33.11 - $55.01 $15,594 - $25,909	-471 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$50.07 - $66.05 $18,626 - $24,570	-372 Reduced 44.13%	471 $24,000
Q1 2020 May 04, 2020	SELL	$49.34 - $68.76 $87,233 - $121,567	-1,768 Reduced 67.71%	843 $49,000
Q2 2019 Jul 30, 2019	BUY	$39.92 - $53.86 $104,231 - $140,628	2,611 New	2,611 $0

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.